Literature DB >> 24831770

Cardiovascular remodelling in coronary artery disease and heart failure.

Gerd Heusch1, Peter Libby2, Bernard Gersh3, Derek Yellon4, Michael Böhm5, Gary Lopaschuk6, Lionel Opie7.   

Abstract

Remodelling is a response of the myocardium and vasculature to a range of potentially noxious haemodynamic, metabolic, and inflammatory stimuli. Remodelling is initially functional, compensatory, and adaptive but, when sustained, progresses to structural changes that become self-perpetuating and pathogenic. Remodelling involves responses not only of the cardiomyocytes, endothelium, and vascular smooth muscle cells, but also of interstitial cells and matrix. In this Review we characterise the remodelling processes in atherosclerosis, vascular and myocardial ischaemia-reperfusion injury, and heart failure, and we draw attention to potential avenues for innovative therapeutic approaches, including conditioning and metabolic strategies.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24831770      PMCID: PMC4330973          DOI: 10.1016/S0140-6736(14)60107-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  130 in total

1.  Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension.

Authors:  Mathias C Brandt; Felix Mahfoud; Sara Reda; Stephan H Schirmer; Erland Erdmann; Michael Böhm; Uta C Hoppe
Journal:  J Am Coll Cardiol       Date:  2012-03-06       Impact factor: 24.094

Review 2.  Mechanisms of cell death in heart disease.

Authors:  Klitos Konstantinidis; Russell S Whelan; Richard N Kitsis
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-05-17       Impact factor: 8.311

3.  Ischemic postconditioning during primary percutaneous coronary intervention: the effects of postconditioning on myocardial reperfusion in patients with ST-segment elevation myocardial infarction (POST) randomized trial.

Authors:  Joo-Yong Hahn; Young Bin Song; Eun Kyoung Kim; Cheol Woong Yu; Jang-Whan Bae; Woo-Young Chung; Seung-Hyuk Choi; Jin-Ho Choi; Jang-Ho Bae; Kyung Joo An; Jong-Seon Park; Ju Hyeon Oh; Sang-Wook Kim; Jin-Yong Hwang; Jae Kean Ryu; Hun Sik Park; Do-Sun Lim; Hyeon-Cheol Gwon
Journal:  Circulation       Date:  2013-09-25       Impact factor: 29.690

Review 4.  Meta-analysis of carvedilol versus beta 1 selective beta-blockers (atenolol, bisoprolol, metoprolol, and nebivolol).

Authors:  James J DiNicolantonio; Carl J Lavie; Hassan Fares; Arthur R Menezes; James H O'Keefe
Journal:  Am J Cardiol       Date:  2013-01-04       Impact factor: 2.778

5.  Towards a re-definition of 'cardiac hypertrophy' through a rational characterization of left ventricular phenotypes: a position paper of the Working Group 'Myocardial Function' of the ESC.

Authors:  Ralph Knöll; Guido Iaccarino; Guido Tarone; Denise Hilfiker-Kleiner; Johann Bauersachs; Adelino F Leite-Moreira; Peter H Sugden; Jean-Luc Balligand
Journal:  Eur J Heart Fail       Date:  2011-06-27       Impact factor: 15.534

Review 6.  Myocardial conditioning: opportunities for clinical translation.

Authors:  Michel Ovize; Hélène Thibault; Karin Przyklenk
Journal:  Circ Res       Date:  2013-08-02       Impact factor: 17.367

7.  Remote ischemic preconditioning reduces myocardial injury after coronary artery bypass surgery with crystalloid cardioplegic arrest.

Authors:  Matthias Thielmann; Eva Kottenberg; Kerstin Boengler; Christoph Raffelsieper; Markus Neuhaeuser; Jürgen Peters; Heinz Jakob; Gerd Heusch
Journal:  Basic Res Cardiol       Date:  2010-05-21       Impact factor: 17.165

8.  Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.

Authors:  C E Murry; R B Jennings; K A Reimer
Journal:  Circulation       Date:  1986-11       Impact factor: 29.690

9.  Remote ischemic preconditioning improves outcome at 6 years after elective percutaneous coronary intervention: the CRISP stent trial long-term follow-up.

Authors:  William R Davies; Adam J Brown; William Watson; Liam M McCormick; Nick E J West; David P Dutka; Stephen P Hoole
Journal:  Circ Cardiovasc Interv       Date:  2013-05-21       Impact factor: 6.546

10.  Arterial disruption and remodeling following balloon dilatation.

Authors:  C K Zarins; C T Lu; B L Gewertz; R T Lyon; D S Rush; S Glagov
Journal:  Surgery       Date:  1982-12       Impact factor: 3.982

View more
  226 in total

1.  The TGF-β pathway mediates doxorubicin effects on cardiac endothelial cells.

Authors:  Zuyue Sun; Jill Schriewer; Mingxin Tang; Jerry Marlin; Frederick Taylor; Ralph V Shohet; Eugene A Konorev
Journal:  J Mol Cell Cardiol       Date:  2015-12-11       Impact factor: 5.000

Review 2.  Inhibition of hypertrophy is a good therapeutic strategy in ventricular pressure overload.

Authors:  Gabriele G Schiattarella; Joseph A Hill
Journal:  Circulation       Date:  2015-04-21       Impact factor: 29.690

Review 3.  The (dys)functional extracellular matrix.

Authors:  Benjamin R Freedman; Nathan D Bade; Corinne N Riggin; Sijia Zhang; Philip G Haines; Katy L Ong; Paul A Janmey
Journal:  Biochim Biophys Acta       Date:  2015-04-27

4.  E2f1 deletion attenuates infarct-induced ventricular remodeling without affecting O-GlcNAcylation.

Authors:  Sujith Dassanayaka; Kenneth R Brittian; Andrea Jurkovic; Lauren A Higgins; Timothy N Audam; Bethany W Long; Linda T Harrison; Giuseppe Militello; Daniel W Riggs; Mitali G Chitre; Shizuka Uchida; Senthilkumar Muthusamy; Anna M Gumpert; Steven P Jones
Journal:  Basic Res Cardiol       Date:  2019-05-31       Impact factor: 17.165

5.  Engineered 3D Cardiac Fibrotic Tissue to Study Fibrotic Remodeling.

Authors:  Amir Hossein Sadeghi; Su Ryon Shin; Janine C Deddens; Giuseppe Fratta; Serena Mandla; Iman K Yazdi; Gyan Prakash; Silvia Antona; Danilo Demarchi; Marc P Buijsrogge; Joost P G Sluijter; Jesper Hjortnaes; Ali Khademhosseini
Journal:  Adv Healthc Mater       Date:  2017-05-12       Impact factor: 9.933

Review 6.  The Role for Cardiovascular Remodeling in Cardiovascular Outcomes.

Authors:  Nishant Krishna Sekaran; Anna Lisa Crowley; Fernanda Rodrigues de Souza; Elmiro Santos Resende; Sunil V Rao
Journal:  Curr Atheroscler Rep       Date:  2017-05       Impact factor: 5.113

7.  Is cardiac magnetic resonance necessary for prediction of left ventricular remodeling in patients with reperfused ST-segment elevation myocardial infarction?

Authors:  Eun Kyoung Kim; Young Bin Song; Sung-A Chang; Sung-Ji Park; Joo-Yong Hahn; Seung Hyuk Choi; Jin-Ho Choi; Hyeon-Cheol Gwon; Seung-Woo Park; Yeon Hyeon Choe; Joonghyun Ahn; Keumhee Carriere; Sang-Chol Lee
Journal:  Int J Cardiovasc Imaging       Date:  2017-06-28       Impact factor: 2.357

8.  Effect of comprehensive remote ischemic conditioning in anterior ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Design and rationale of the CORIC-MI randomized trial.

Authors:  Li Song; Hongbing Yan; Peng Zhou; Hanjun Zhao; Chen Liu; Zhaoxue Sheng; Yu Tan; Chen Yi; Jiannan Li; Jinying Zhou
Journal:  Clin Cardiol       Date:  2018-08-16       Impact factor: 2.882

9.  Toll-interacting protein contributes to mortality following myocardial infarction through promoting inflammation and apoptosis.

Authors:  Nian Wan; Xiaoxiong Liu; Xiao-Jing Zhang; Yichao Zhao; Gangying Hu; Fengwei Wan; Rui Zhang; Xueyong Zhu; Hao Xia; Hongliang Li
Journal:  Br J Pharmacol       Date:  2015-04-24       Impact factor: 8.739

10.  Vago-Splenic Axis in Signal Transduction of Remote Ischemic Preconditioning in Pigs and Rats.

Authors:  Helmut Raphael Lieder; Petra Kleinbongard; Andreas Skyschally; Helene Hagelschuer; William M Chilian; Gerd Heusch
Journal:  Circ Res       Date:  2018-10-26       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.